Username  Password  Create an account
Forgot password
Search 
OUR MISSION is to improve the quality of life of people who have psoriasis and psoriatic arthritis. Through education and advocacy, we promote awareness and understanding, ensure access to treatment and support research that will lead to effective management and, ultimately, a cure.
News & Events Overview
Events Calendar
Community education meetings
National Conference
National Psoriasis Walk for Awareness
Online Chats
Psoriasis Awareness Month
News Stories
2006 news stories
2005 news stories
2004 news stories
2003 news stories
2002 news stories
2001 news stories
Press Releases
  Donate
  Take action
  Talk here

ZIP CODE SEARCH
Find support groups, doctors and events near you.

News and events
2003 news stories

Amevive approved for psoriasis treatment Jan. 31, 2003

Psoriasis hits the silver screen in "The Singing Detective" March 18, 2003

AAD dispatches 2003: New therapies discussed March 21, 2003

Arthritis treatments evaluated April 7, 2003

Oral form of non-steroidal treatment shows promise April 9, 2003

Oral form of Tazorac studied for psoriasis April 9, 2003

First local meeting informs and educates April 17, 2003

Rheumatoid arthritis drug in trials for psoriasis and psoriatic arthritis April 29, 2003

FDA approves updated Soriatane label May 23, 2003

Skin peel chemical linked to sunburn June 12, 2003

Amevive study shows intramuscular results July 1, 2003

Global Enbrel study supports previous findings July 1, 2003

Raptiva data shows continued improvement July 8, 2003

Enbrel filed for approval for psoriasis treatment July 8, 2003

National Psoriasis Foundation teams with Yahoo! to create Psoriasis Health Center July 31, 2003

National conference attendees enjoy weekend of education, interaction Aug. 12, 2003

Researchers compare Methotrexate and Cyclosporine for first time Aug. 26, 2003

Enbrel receives new indication for psoriatic arthritis Aug. 28, 2003

Psoriasis Foundation to testify before FDA panel reviewing Raptiva Sept. 3, 2003

Federal advisory committee recommends approval of new psoriasis drug Sept. 10, 2003

Pregnancy and psoriasis: Q&A from 2003 National Conference Sept. 16, 2003

New administration procedures for Amevive and Enbrel Sept. 19, 2003

Enbrel moves to once-weekly dose Oct. 22, 2003

FDA approves new psoriasis drug Oct. 27, 2003

Researchers link psoriasis to increased lymphoma rate Nov. 21, 2003

National Psoriasis Foundation mourns the passing of founder Beverly Foster Halprin Nov. 21, 2003

New oral retinoid submitted for FDA approval Dec. 3, 2003


Home About Us Contact Us Privacy & Terms Site Map
Copyright ©2008 National Psoriasis Foundation/USA